GNMX
Aevi Genomic Medicine, Inc.
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
51 hedge funds and large institutions have $54.9M invested in Aevi Genomic Medicine, Inc. in 2015 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 25 increasing their positions, 8 reducing their positions, and 8 closing their positions.
Holders
51
Holders Change
-3
Holders Change %
-5.56%
% of All Funds
1.43%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
5
Increased
25
Reduced
8
Closed
8
Calls
$322K
Puts
$9K
Net Calls
+$313K
Net Calls Change
+$330K
Top Buyers
| 1 |
BC
1
Broadfin Capital
New York
|
$12.1M |
| 2 |
QF
2
QVT Financial
New York
|
$2.09M |
| 3 |
3
Jennison Associates
New York
|
$6.58M |
| 4 |
4
Northern Trust
Chicago,
Illinois
|
$1.41M |
| 5 |
BGA
5
Belmont Global Advisors
Dallas,
Texas
|
$1.21M |
